Brian Skorney Analyst PerformanceSenior Research Analyst at Robert W. BairdBrian Skorney is a stock analyst at Robert W. Baird focused in the medical sector, covering 25 publicly traded companies. Over the past year, Brian Skorney has issued 20 stock ratings, including buy and hold recommendations. While full access to Brian Skorney's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Brian Skorney's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings167 Last 11 YearsBuy Recommendations71.78% 117 Buy RatingsCompanies Covered25 Unique Companies Ratings Distribution163RatingsDistribution of strong buy, buy, hold, and sell ratings by Brian Skorney.RatingPercentageCount Strong Buy0.0%0 ratings Buy71.8%117 ratings Hold25.8%42 ratings Sell2.5%4 ratingsOut of 163 total stock ratings issued by Brian Skorney at Robert W. Baird, the majority (71.8%) have been Buy recommendations, followed by 25.8% Hold and 2.5% Sell.Best & Worst CallsBest Call0000.0%SRPTApr 2017Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%ICPTDec 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ88.0% of companies on NASDAQ22 companiesNYSE12.0% of companies on NYSE3 companiesBrian Skorney, an analyst at Robert W. Baird, currently covers 25 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical24 companies96.0%Aerospace1 company4.0%Brian Skorney of Robert W. Baird specializes in stock coverage within the Medical sector, with additional focus on Aerospace companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE15 companies60.0%MED - DRUGS6 companies24.0%BIOTECHNOLOGY1 company4.0%MED - GENERIC DRG1 company4.0%PHARMACEUTICAL PREPARATIONS1 company4.0%AEROSP/DEF EQ1 company4.0% About Brian SkorneyBrian Skorney is a Baird Senior Research Analyst covering Biotechnology. Prior to joining Baird in 2012, he was a senior vice president in equity research at Brean Murray Carrett & Co, a vice president in equity research at ThinkEquity, LLC and a research analyst at Susquehanna International Group, LLC, all in the biotech/pharmaceutical industry. He also worked as a coordinator and lab manager at the Howard Hughes Medical Institute. Brian was ranked by TipRanks as No. 75 on the Top 100 Wall Street analysts of 2019 list. In 2016, he was ranked by Thomson Reuters Analyst Awards (StarMine) as the No. 3 stock picker in Biotechnology. Brian received a BS in Biological Sciences from the University of Notre Dame and an MBA in Finance from New York University. Brian Skorney's Ratings History at Robert W. Baird Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsANROAlto Neuroscience5/18/2026Lower Price Target$23.12$36.00Outperform$0.0000.00% ROIMIRMMirum Pharmaceuticals5/7/2026Boost Price Target$110.08$129.00Outperform$0.0000.00% ROIMIRMMirum Pharmaceuticals4/28/2026Boost Price Target$92.48$112.00Outperform$0.0000.00% ROIANROAlto Neuroscience4/2/2026Lower Price Target$22.42$38.00Outperform$0.0000.00% ROIANROAlto Neuroscience3/18/2026Boost Price Target$22.51$41.00Outperform$0.0000.00% ROIXENEXenon Pharmaceuticals3/9/2026Boost Price Target$62.76$97.00Outperform$0.0000.00% ROIRGNXREGENXBIO2/10/2026Set Price Target$8.86$27.00$0.0000.00% ROISLNOSoleno Therapeutics1/13/2026Set Price Target$40.26$107.00$0.0000.00% ROIMIRMMirum Pharmaceuticals12/8/2025Boost Price Target$67.90$88.00Outperform$0.0000.00% ROIDYNDyne Therapeutics12/8/2025Set Price Target$22.00$30.00$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. ANROAlto Neuroscience11/13/2025Boost Price Target$14.21$22.00Outperform$0.0000.00% ROIBHVNBiohaven11/5/2025Set Price Target$13.97$42.00$0.0000.00% ROISRPTSarepta Therapeutics11/4/2025Lower Price Target$24.45$15.00Neutral$0.0000.00% ROIANROAlto Neuroscience10/20/2025Boost Price Target$10.99$16.00Outperform$0.0000.00% ROICRNXCrinetics Pharmaceuticals9/26/2025Boost Price Target$35.89$62.00Outperform$0.0000.00% ROIBHVNBiohaven8/12/2025Lower Price Target$13.42$52.00Outperform$0.0000.00% ROISRPTSarepta Therapeutics7/17/2025Boost Price Target$18.38$35.00Outperform$0.0000.00% ROISLNOSoleno Therapeutics7/11/2025Set Price Target$80.32$121.00Outperform$0.0000.00% ROIDYNDyne Therapeutics6/18/2025Lower Price Target$10.81$32.00Outperform$0.0000.00% ROISRPTSarepta Therapeutics6/17/2025Lower Price Target$21.28$30.00Outperform$0.0000.00% ROISLNOSoleno Therapeutics5/8/2025Boost Price Target$74.66$105.00Outperform$00.0000.00% ROIBIIBBiogen5/2/2025Lower Price Target$120.93$255.00Outperform$000.0000.00% ROIBHVNBiohaven4/28/2025Lower Price Target$19.81$57.00Outperform$0.0000.00% ROIREGNRegeneron Pharmaceuticals4/25/2025Lower Price Target$599.76$652.00Neutral$000.0000.00% ROISLNOSoleno Therapeutics3/27/2025Boost Price Target$48.97$102.00Outperform$00.0000.00% ROIMIRMMirum Pharmaceuticals2/27/2025Boost Price Target$50.52$55.00Outperform$00.0000.00% ROIREGNRegeneron Pharmaceuticals2/5/2025Lower Price Target$722.27$759.00Neutral$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupMorgan StanleyRoyal Bank Of CanadaJefferies Financial GroupThe Goldman Sachs GroupStifel NicolausRaymond James FinancialMizuhoBank of AmericaKeyCorpSanford C. BernsteinWolfe ResearchCICC Research Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
